Researchers from NYU Grossman School of Medicine found people previously infected with the SARS-CoV-2 coronavirus may produce enough antibodies against COVID-19 after one dose of the Pfizer–BioNTech COVID-19 vaccine that is equal to or higher than people not previously infected have after two vaccinations.
Short-Course Antibiotics Noninferior for Pediatric Pneumonia
Short-course antibiotic therapy comparable to standard care for community-acquired pneumonia
COVID-19 Vaccine Hesitancy, Mistrust High Among Black Americans
High hesitancy even seen among Black health care workers, survey finds
Alcohol Withdrawal Rates Up in Hospitalized Patients During Pandemic
Rates for hospitalized patients consistently higher compared with 2019
Most Women Would Vaccinate Their Children Against COVID-19
And, more than half of pregnant women would also accept a COVID-19 vaccine for themselves
Risk for Severe Outcomes in COVID-19 Increases With Increasing BMI
Risks for hospitalization, intensive care unit admission, and death increased sharply with higher BMIs
States, Pharmacies to Receive Additional Doses of COVID-19 Vaccines
The United States is now delivering an average of 2.17 million doses of COVID-19 vaccines a day